申请人:The Boots Company Limited
公开号:US04443449A1
公开(公告)日:1984-04-17
Compounds of formula I ##STR1## in which R.sub.1 is H or C.sub.1-3 alkyl; R.sub.2 is H or C.sub.1-3 alkyl; R.sub.3 and/or R.sub.4 are H, C.sub.1-3 alkyl, C.sub.3-6 alkenyl, C.sub.3-6 alkynyl, C.sub.3-7 cycloalkyl or R.sub.3 and R.sub.4 together with the nitrogen atom form a heterocyclic ring system; R.sub.5 and/or R.sub.6 are H, halo, CF.sub.3, or C.sub.1-3 alkyl (with the proviso that R.sub.5 and R.sub.6 cannot both be H or methyl) or R.sub.5 and R.sub.6 together with the carbon atoms to which they are attached form a second benzene ring and R.sub.7 and/or R.sub.8 are H or C.sub.1-3 alkyl show therapeutic activity in the treatment of depression. Pharmaceutical compositions and processes for preparing compounds of formula I are disclosed.
式I的化合物 ##STR1## 其中R.sub.1为H或C.sub.1-3烷基;R.sub.2为H或C.sub.1-3烷基;R.sub.3和/或R.sub.4为H、C.sub.1-3烷基、C.sub.3-6烯基、C.sub.3-6炔基、C.sub.3-7环烷基或R.sub.3和R.sub.4与氮原子一起形成杂环环系;R.sub.5和/或R.sub.6为H、卤素、CF.sub.3或C.sub.1-3烷基(但R.sub.5和R.sub.6不能同时为H或甲基),或R.sub.5和R.sub.6与它们附着的碳原子一起形成第二个苯环,R.sub.7和/或R.sub.8为H或C.sub.1-3烷基,在治疗抑郁症方面具有治疗活性。还公开了制备式I化合物的药物组合物和过程。